Phylogeny and molecular epidemiology of HTLV in Hormozgan province

O-1

Predominant Epidemiologic Patterns of HTLV-I in Endemic Area of Iran

P-2

The major risk factors of HTLV-I infection in Iranian HTLV-I infected individuals

O-3

The seroprevalence of HTLV-I in pregnant women of Mashad

P-4

Prevalence of Human T Lymphotrophic Virus (HTLV)1,2 Among Tissue Donors in Iranian Tissue Bank

O-5

Knowledge, attitude and practice of nursing and midwifery staff about HTLV_1 in Mashhad: North East of Iran. 2007

O-6

Frequency of HIV/HTLV-I co- infected subjects in Mashhad- Iran in 2009

O-7

Evaluation of blood indices as predictive markers in co-infected HIV\HTLV-I subjects

O-8

HTLV-1 Epidemiology in Neyshabour, Northeast of Iran

P-9

Prevalence of Multiple Sclerosis and Human Thymus Lymphocyte Virus-I infection In Khorasan Territory

O-10

The Prevalence and Risk Factor of HTLV1 Infection among Health Care Workers in Ghaem Hospital, Mashhad

O-11

Co-infection between HTLV1,2 and other transfusion transmissible viral infections in mashhadi blood donors

P-12

HTLV 1(Human T lymphocyte virus type 1) in pregnancy and breastfeeding

O-13

Seroepidemiology of HTLV-I in Iran: An Overview

P-14

HTLV- I infection in the general population of Mashhad, Iran:Prevalence and risk factors

O-15

SOCIODEMOGRAPHIC CHARACTERISTICS OF HTLV-1 POSITIVE BLOOD DONORS IN MASHHAD IN 2009

O-16

Frequency of HTLV-I among individuals with bleeding disorders in North-Eastern Iran

O-17

Seroprevalence of HTLV 1, 2 viruses among injection drug users in Isfahan 2007-2008

O-18

Prevalence of HTLV-1 infection in Golestan Province

O-19

Is HTLV1 screening necessary before cardiac catheterization of congenital heart diseases?

P-20

Increased risk of HTLV-I effect in he pathpgenesis of CML and AML patients

O-21

Seroprevalence of HTLV-I among kidney graft Recipients: A single center study

P-22

Survey the of HTLV I /II in Hemodialysis patients and Bloseroprevalenceand donors In Urmia

O-23

Frequency of minor blood groups among confirmed Human T-lymphotropic virus 1 infected subjects

P-24

Western blot seroindeterminate individuals for human T-lymphotropic virus 1/2 (HTLV 1/2) in Northeast of Iran

P-25

Seroindeterminate HTLV 1/2 prevalence and characteristics in blood donors of Northeast of Iran

O-26

Comparison of the incidence of the HTLV-I infection in childhood leukemia, non Hodgkin’s lymphoma, Thalassemia and volunteer blood donors in Fars province

P-27

Serologic Prevalence of HTLV among Blood Donors in Mashhad (Northeastern Iran)

O-28

A Study of Infection with HTLV-1 in Referring Patients to the Emam-Reza Hospital Clinic in One Year

P-29

Frequency of Human T-Lymphotropic Virus Type 1,2 among Blood Donors from Karaj blood transfusion center

P-30

The assessment of HTLV-1 prevalence and coinfection with HBV, HCV and KSHV in prisoners of Mashhad prison

O-31

Is HTLV-1 infection associated with ABO and Rhesus blood group types? An evidence from Northeast Iran

O-32

Role of Th1 and Th2 cytokines in immune response to HTLV-I associated Myelopathy/Tropical Spastic Paraparesis

O-33

Acute lymphoproliphrative disorders induced by HTLV-1; Review of literatures and report a case

P-34

Detection of HTLV-1 genome in primary gastrointestinal lymphomas:A study on 22 years (1981- 2003) pathology archive biopsy specimens in Imam Reza Hospital, Mashhad, Iran

O-35

Relationships between polymorphisms of Vitamin D Receptor (VDR) genes and susceptibility to HTLV-1 virus in Khorasan population

O-36

An optimized cut-off point for ELISA test in detection of HTLV-1 infection

O-37

Association between VEGFa serum levels and HTLV1 infection

O-38

Geographic Heterogeneity of Cytogenetic Characteristics of Acute Myeloid Leukemia in the early detection: A possible infection with HTLV1

P-39

The role of P53 codon 72 polymorphism in the pathogenesis of ATL among HTLV-I carriers

O-40

Dendritic Cell Tolerogenicity in Immunomodulation by Vitamin D in HTLV-1- Associated Adult T-cell Leukemia/Lymphoma

P-41

Detection of HTLV-1 DNA in Non-hodgkin lymphoma

O- 42

Cytokine production by endothelial cells infected with HTLV-1 is one of the mechanisms of viral entry into CNS

P- 43

Molecular analysis of human lymphotropic virus type 1 and 2 seroindeterminate blood donors from Northeast of Iran; evidence of proviral tax, env, and gag sequences

O- 44

Detection of HTLV-1 DNA in Mycosis Fungoides by PCR

O- 45

Screening of HTLV-1 infected individuals for detection of Tax gene deletion

O- 46

Prevalence of ATLL in leukemia patient referred to Flow cytometry lab in Buali research institute and correlation with HTLV1 infection

O- 47

Association between HLA-DQB1 alleles and patients with HAMS/TSP in the endemic Khorasan province

O- 48

The impact of Interferon-alpha treatment on clinical, and immunovirological aspects of HTLV-I-associated myelopathy in Khorasan-Iran

O- 49

Prevalence of Multiple Sclerosis and Human Thymus Lymphocyte Virus-I infection in Khorasan Territory

O-50

Tropical spastic paraparesia in 40 year woman in doroud city

P-51

PREDNISOLONE AS A NEW APPROACH FOR TREATMENT OF HTLV-1 ASSOCIATED OLYNEUROPATHY

O-52

Urinary and Sexual Dysfunction in HAM/TSP patients

O-53

HTLV-I proviral load in HAM/TSP patients and healthy carriers

O-54

Khorasan disease in Azarbaijan (a 3 years study): Duration prevalence of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in west Azarbaijan from 2004 to 2007

O-55

Guillain-Barre'-like syndrome as a rare presentation of Adult T-cell Leukemia- Lymphoma (ATLL)

O-56

Epidemiology of HTLV-I in Japan and Therapeutic strategies for HAM/TSP

O -57

FOUR CASES OF POLYNEUROPATHY DUE TO HTLV1 INFECTION IN IMAM REZA HOSPITAL (NORTH EAST OF IRAN)

O-58

Results of clinical and para-clinical study about serum, Cerebrespinal Fluid, HLA typing and MRI in 103 HAM/TSP patients

O-59

VEP findings in the patients with HAM/TSP

O-60

Therapeutic Effects of Danazol in HTLV-1 Associated Myelopathy

O-61

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)

O-62

The effect of arsenic trioxide, interferon alpha, and zidovudine therapy on T cell phenotype in patients with adult T cell leukemia

O-63

Clinical and Laboratory Features in Adult T- Cell Leukemia/Lymphoma in Mashhad

P-64

The impact of HTLV-I coinfection on HIV Viral load , immunophenotypic markers And HIV clinical outcome

O-65

HTLV-1 Associated intestinal Lymphoma (A case report)

P-66

Seizure and loss of consciousness in a case of human T lymphotropic virus type 1 ( HTLV-1) Associated leukemia/lymphoma

P-67

Bullous Pemphigoid (BP) and Human T lymphotropic virus Type 1- (HTLV1) comorbidity – a case report

P-68

Diffuse normolipaemic plane xanthomatosis associated with Adult T- cell lymphoma/ leukemia

P-69

Specific cutaneous manifestations in Adult T cell leukemia /lymphoma

O-70

Evaluation of relationship between HTLV1 infection and dermatologic manifestations

O-71

Dermatologic Manifestations in HTLV1 Positive compared with HTlV1 negative individuals

O-72

Association of Human T-cell Lymphotropic Virus Type 1 (HTLV-1) Infection and Rheumatoid Arthritis

P-73

The sero-prevalence of HTLV-1 infection in coronary arteries disease in Mashhad and Neishbour patients in 2007 and 2008

O-74

Head and Neck manifestations of HTLV-I infection

P-75

Evaluation of Phenotypic markers in HTLV-I co-infected in 66 HIV positive subjects in Mashhad-Iran

O-76

The evaluation of periodontium in patients with spastic parapareseis related to HTLV-I

O-77

Prevalence of glucose abnormalities in HTLV-I carriers

O-78